This collection of essays represents the work produced in the course of a three-year project funded by the Commission of the European Communities under the Biomed I programme, on the ethics of genetic screening, entitled 'Genetic screening: ethical and philosophical perspectives, with special reference to multifactorial diseases'. The short title of the project was Euroscreen, thereafter known as Euroscreen I, in the light of the fact that a second project on genetic screening was subsequently funded. The project was multinational and multidisciplinary, and had as its objectives to examine the nature and extent of genetic screening programmes in different European countries; to analyse the social policy response to these developments in different countries; and to explore the applicability of normative ethical frameworks to the issues. The project was led by a core group who had oversight of the project and members of which have acted as editors for this volume. Darren Shickle edited the first section; Henk ten Have the second; Ruth Chadwick and Urban Wiesing the third and final part. The volume opens with an overview of genetic screening and the principles available for addressing developments in the field, with special reference to the Wilson and Jungner principles on screening. The first of the three major sections thereafter includes papers on the state of the art in different countries, together with some analysis of social context and policy.

As the use of human body parts has become increasingly commercialized, a need has arisen for new approaches to regulation that moves beyond the paradigm of altruism. During the course of this discussion, the notion of property has become a key concept. Focusing on practical and conceptual perspectives, the multidisciplinary group of authors, which includes specialists in philosophy, law, sociology, biology and medicine, have come together with practicing lawyers to consider both legal provisions and patterns of regulation in countries across Europe. Identifying divergences between different legal traditions, the authors explore various conceptual models which could be used to improve and to guide policy making. With this twin focus on practical and conceptual perspectives, this volume sets the standard for a detailed and innovative discussion of issues surrounding the regulation of research on human tissue.

With the advances of medicine, questions of medical ethics have become more urgent and are now considered of great social and political significance. An innovatively designed, activity-based workbook, this text was prepared using papers and case studies collected from several countries in the European Union. It reflects the issues and concerns that confront clinical practitioners throughout Europe and elsewhere today and presents varying national responses in law and policy to these concerns, as identified by ethicists, lawyers, theologians and practitioners. The problems they examine include the relationship between medical research and medical practice, elementary regulations of medical research, the complexity of informed consent, and the role of the sponsor or scientific community.

As the use of human body parts has become increasingly commercialized, a need has arisen for new approaches to regulation that moves beyond the paradigm of altruism. During the course of this discussion, the notion of property has become a key concept. Focusing on practical and conceptual perspectives, the multidisciplinary group of authors, which includes specialists in philosophy, law, sociology, biology and medicine, have come together with practicing lawyers to consider both legal provisions and patterns of regulation in countries across Europe. Identifying divergences between different legal traditions, the authors explore various conceptual models which could be used to improve and to guide policy making. With this twin focus on practical and conceptual perspectives, this volume sets the standard for a detailed and innovative discussion of issues surrounding the regulation of research on human tissue.

This collection of essays represents the work produced in the course of a three-year project funded by the Commission of the European Communities under the Biomed I programme, on the ethics of genetic screening, entitled 'Genetic screening: ethical and philosophical perspectives, with special reference to multifactorial diseases'. The short title of the project was Euroscreen, thereafter known as Euroscreen I, in the light of the fact that a second project on genetic screening was subsequently funded. The project was multinational and multidisciplinary, and had as its objectives to examine the nature and extent of genetic screening programmes in different European countries; to analyse the social policy response to these developments in different countries; and to explore the applicability of normative ethical frameworks to the issues. The project was led by a core group who had oversight of the project and members of which have acted as editors for this volume. Darren Shickle edited the first section; Henk ten Have the second; Ruth Chadwick and Urban Wiesing the third and final part. The volume opens with an overview of genetic screening and the principles available for addressing developments in the field, with special reference to the Wilson and Jungner principles on screening. The first of the three major sections thereafter includes papers on the state of the art in different countries, together with some analysis of social context and policy.

Das Buch dokumentiert die Beitrage des internationalen Symposiums "Assistierter Suizid: Der Stand der Wissenschaft" vom 15. Juni 2015 in Berlin. Es bietet einen einmaligen Uberblick uber die aktuellen empirischen Untersuchungen zum Thema, die in der politischen Debatte teilweise schlicht ignoriert wurden und immer noch ignoriert werden. Es enthalt ausserdem die Transkripte aufschlussreicher Pro-Contra Debatten zwischen Vertretern unterschiedlicher Positionen aus den Fachgebieten Recht, Medizin und Ethik. Am Schluss steht eine ausfuhrliche Kommentierung des neuen Gesetzes "zur Strafbarkeit der geschaftsmassigen Forderung der Selbsttotung" aus rechtlicher, medizinischer und ethischer Perspektive.Die Autoren und Herausgeber sind international ausgewiesene Experten aus Deutschland und aus anderen Staaten, in denen die Totung auf Verlangen und/oder der assistierte Suizid gesetzlich geregelt sind (Niederlande, Schweiz, USA).

Mit der Geburt des ersten "Retortenbabys" 1978 konzentrierten sich das Interesse und die Befurchtungen auf die spektakularen Moglichkeiten, die sich plotzlich eroffneten. Doch die Sorge um das Aussergewohnliche lenkte den Blick von der alltaglichen Praxis ab. Die In-vitro-Fertilisation konnte sich weltweit etablieren, ohne dass ihre Effektivitat wissenschaftlich nachgewiesen ware. Dieses Buch leistet zum ersten Mal anhand empirischer Ergebnisse eine umfassende Bestandsaufnahme und kritische Analyse der Erfolge sowie der unerwunschten korperlichen und seelischen Wirkungen. Es hinterfragt die gebrauchlichen Indikationen und Diagnosen und untersucht, inwieweit die Praxis der In-vitro-Fertilisation mit den ethischen Richtlinien der Arzteschaft (Hippokratischer Eid, rev. Deklaration von Helsinki) in Einklang steht. Das Ergebnis: Die In-vitro-Fertilisation ist ein umstrittenes "Experiment," bei dem wenige gewinnen und viele verlieren."